Kurogane Kosakusho Ltd.
Kurogane Kosakusho Ltd. (7997.T) Financial Performance & Income Statement Overview
Explore the financials of Kurogane Kosakusho Ltd. (7997.T), including yearly and quarterly data on income, cash flow, and balance sheets.
Kurogane Kosakusho Ltd. (7997.T) Income Statement & Financial Overview
Review Kurogane Kosakusho Ltd. 7997.T income statement with detailed quarterly and annual figures.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $1.37B | $1.74B | $1.44B | $2.28B |
Cost of Revenue | $1.08B | $1.35B | $1.18B | $1.76B |
Gross Profit | $285.05M | $391.25M | $256.81M | $522.79M |
Gross Profit Ratio | $0.21 | $0.22 | $0.18 | $0.23 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $9.00M |
SG&A Expenses | $386.05M | $394.16M | $376.49M | $402.59M |
Operating Expenses | $386.05M | $394.16M | $376.49M | $411.59M |
Total Costs & Expenses | $1.47B | $1.74B | $1.56B | $2.17B |
Interest Income | $221000.00 | $8000.00 | $47000.00 | $0.00 |
Interest Expense | $4.13M | $4.03M | $4.25M | $3.32M |
Depreciation & Amortization | $36.84M | $40.50M | $39.54M | $35.02M |
EBITDA | -$53.009M | $210.06M | $1.02M | $160.88M |
EBITDA Ratio | -$0.04 | $0.12 | $0.001 | $0.07 |
Operating Income | -$101.00M | -$2.90M | -$119.67M | $111.19M |
Operating Income Ratio | -$0.07 | -$0.002 | -$0.08 | $0.05 |
Other Income/Expenses (Net) | $7.02M | $168.43M | $76.91M | $11.35M |
Income Before Tax | -$93.97M | $165.53M | -$42.76M | $122.55M |
Income Before Tax Ratio | -$0.07 | $0.10 | -$0.03 | $0.05 |
Income Tax Expense | $4.75M | $24.55M | -$21.44M | $28.15M |
Net Income | -$98.33M | $142.76M | -$19.64M | $94.22M |
Net Income Ratio | -$0.07 | $0.08 | -$0.01 | $0.04 |
EPS | -$57.72 | $83.81 | -$11.53 | $55.31 |
Diluted EPS | -$57.72 | $83.81 | -$11.53 | $55.31 |
Weighted Avg Shares Outstanding | $1.70M | $1.70M | $1.70M | $1.70M |
Weighted Avg Shares Outstanding (Diluted) | $1.70M | $1.70M | $1.70M | $1.70M |
Financial performance has remained strong, with revenue growing from $2.28B in Q2 2024 to $1.37B in Q1 2025. Gross profit continued to perform well, with margins at 21% in the latest quarter. Operating income reached -$101.00M in Q1 2025, holding a steady -7% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at -$53.009M. Net income dropped to -$98.33M, keeping EPS at -$57.72. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan